Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Bought by Sanctuary Advisors LLC

Sanctuary Advisors LLC raised its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 5.4% during the fourth quarter, Holdings Channel reports. The firm owned 18,175 shares of the company’s stock after purchasing an additional 927 shares during the period. Sanctuary Advisors LLC’s holdings in Prestige Consumer Healthcare were worth $1,425,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Creative Planning lifted its stake in shares of Prestige Consumer Healthcare by 32.6% in the 3rd quarter. Creative Planning now owns 10,011 shares of the company’s stock worth $722,000 after acquiring an additional 2,460 shares during the period. Blue Trust Inc. increased its stake in Prestige Consumer Healthcare by 102.4% in the 3rd quarter. Blue Trust Inc. now owns 1,755 shares of the company’s stock valued at $121,000 after buying an additional 888 shares during the period. Raymond James & Associates increased its stake in Prestige Consumer Healthcare by 3.7% in the 3rd quarter. Raymond James & Associates now owns 122,144 shares of the company’s stock valued at $8,807,000 after buying an additional 4,342 shares during the period. Private Advisor Group LLC grew its position in Prestige Consumer Healthcare by 15.6% in the third quarter. Private Advisor Group LLC now owns 3,380 shares of the company’s stock worth $244,000 after acquiring an additional 457 shares in the last quarter. Finally, International Assets Investment Management LLC boosted its holdings in shares of Prestige Consumer Healthcare by 7,112.5% during the 3rd quarter. International Assets Investment Management LLC now owns 1,154 shares of the company’s stock worth $83,000 after buying an additional 1,138 shares during the period. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Trading Up 2.8 %

Shares of Prestige Consumer Healthcare stock opened at $87.46 on Wednesday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. The stock has a market capitalization of $4.33 billion, a P/E ratio of 20.48, a P/E/G ratio of 2.69 and a beta of 0.50. Prestige Consumer Healthcare Inc. has a 52-week low of $62.35 and a 52-week high of $88.36. The stock’s 50-day simple moving average is $79.53 and its 200 day simple moving average is $76.75.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. As a group, research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. Canaccord Genuity Group boosted their price objective on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a report on Friday, February 7th. Oppenheimer boosted their price objective on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Friday, January 24th. Finally, Sidoti lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective on the stock. in a research report on Monday, December 9th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $92.60.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.